Literature DB >> 2375634

Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease.

H S Mayberg1, S E Starkstein, B Sadzot, T Preziosi, P L Andrezejewski, R F Dannals, H N Wagner, R G Robinson.   

Abstract

Depression is a frequent finding in patients with Parkinson's disease (PD). Regional cerebral glucose metabolism was measured in depressed and nondepressed patients with PD and in age-comparable normal control subjects using 2-[18F]-fluoro-2-deoxy-D-glucose and positron emission tomography (PET). Relative metabolic activity in the caudate and orbital-inferior region of the frontal lobe was significantly lower in the depressed patients with PD as compared to both nondepressed patients and control subjects. There was a significant inverse correlation between relative glucose metabolism in the orbital-inferior area of the frontal lobe and depression scores. This study suggests that depression in PD is associated with dysfunction in the caudate and orbital-inferior area of the frontal lobe. This metabolic pattern is unlike that seen in patients with PD who have other behavioral deficits such as dementia, and suggests that disruption of basal ganglia circuits involving the inferior region of the frontal lobe may affect the regulation of mood.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375634     DOI: 10.1002/ana.410280111

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  65 in total

1.  Apathy and depression: separate factors in Parkinson's disease.

Authors:  Lindsey Kirsch-Darrow; Michael Marsiske; Michael S Okun; Russell Bauer; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2011-11       Impact factor: 2.892

2.  Brain mechanisms of stress and depression in coronary artery disease.

Authors:  J Douglas Bremner; Carolina Campanella; Zehra Khan; Negar Fani; Nicole Kasher; Sarah Evans; Collin Reiff; Sanskriti Mishra; Stacy Ladd; Jonathon A Nye; Paolo Raggi; Viola Vaccarino
Journal:  J Psychiatr Res       Date:  2018-11-22       Impact factor: 4.791

3.  Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.

Authors:  Daniel Weintraub; Donna Taraborelli; Knashawn H Morales; John E Duda; Ira R Katz; Matthew B Stern
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

4.  Dopaminergic modulation of memory and affective processing in Parkinson depression.

Authors:  Lee X Blonder; John T Slevin; Richard J Kryscio; Catherine A Martin; Anders H Andersen; Charles D Smith; Frederick A Schmitt
Journal:  Psychiatry Res       Date:  2013-07-06       Impact factor: 3.222

5.  Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy?

Authors:  R M Debets; B Sadzot; J W van Isselt; G J Brekelmans; L C Meiners; A O van Huffelen; G Franck; C W van Veelen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

6.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

7.  Depression in Parkinson's disease. Diffusion tensor imaging study.

Authors:  Hideaki Matsui; Kazuto Nishinaka; Masaya Oda; Hidekazu Niikawa; Kenichi Komatsu; Tamotsu Kubori; Fukashi Udaka
Journal:  J Neurol       Date:  2006-08-20       Impact factor: 4.849

8.  Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.

Authors:  Gregor Hasler; Stephen Fromm; Paul J Carlson; David A Luckenbaugh; Tracy Waldeck; Marilla Geraci; Jonathan P Roiser; Alexander Neumeister; Noah Meyers; Dennis S Charney; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2008-05

Review 9.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 10.  Comparison of prefrontal cell pathology between depression and alcohol dependence.

Authors:  José J Miguel-Hidalgo; Grazyna Rajkowska
Journal:  J Psychiatr Res       Date:  2003 Sep-Oct       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.